Fertility Preservation: Clinical Trials

41 trials for Fertility Preservation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 recruiting, 11 completed, 8 unknown, 4 not yet recruiting. 15 Not applicable, 4 Phase 3, 2 Phase 2, 2 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 6, Recruiting 4, Not yet recruiting 2, Active not recruiting 1, Suspended 1, Unknown 1
Phase 34Completed 2, Not yet recruiting 1, Recruiting 1
Phase 22Completed 1, Recruiting 1
Phase 42Recruiting 2
Early Phase 11Unknown 1

Follow Fertility Preservation: new trials by email Literature Review of Fertility Preservation trials Research Report on Fertility Preservation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Nafarelin For Triggering Oocyte Maturation
Subcutaneous Triptorelin, Intranasal nafarelin - Fertility Preservation
Phase 4RecruitingFundacion Dexeus1542026-10-142026-10-15
A Modular Cloud Platform For Fertility Preservation
Developing a Modular Cloud-Based Platform to guide decision-making in fertility preservation - Fertility Preservation, Gynecologic Cancers
Not applicableNot yet recruitingBiruni University1402026-09-022026-06-12
Follicular Flushing Versus Direct Aspiration in Transabdominal Oocyte Retrieval
Fertility Preservation
RecruitingCentrum Clinic IVF Center1802026-08-202026-10-20
Decision Aid for Elective Egg Freezing
elective egg freezing decision aid - Elective Egg Freezing, Oocyte Cryopreservation
Not applicableNot yet recruitingNational Taiwan University Hospital1202026-04-132026-04-21
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
OCP pause - Fertility Preservation
Not applicableRecruitingShady Grove Fertility Reproductive Science Center3942026-02-252026-03-02
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
Fertility Preservation, Cancer Remission
RecruitingCentre Hospitalier Universitaire, Amiens1022025-12-172026-01-16
Digital Health Literacy and Oocyte Cryopreservation Among Women With Gynecological Cancer
Digital Health Literacy Education Intervention - Gynecological Cancer, Oocyte Cryopreservation
Not applicableCompletedBenha University1582025-09-012026-07-14
Ovarian Tissue Cryopreservation Combined With Oocyte Cryopreservation Versus Oocyte Cryopreservation Alone
Oncological Disease, Fertility Preservation
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1272025-08-252026-04-22
Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment
Hysteroscopic Resection and Hormonal Therapy - Endometrial Adenocarcinoma, Endometrial Hyperplasia
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1002025-06-202025-07-22
Ovulation Induction With GnRH Analogue or Dual Trigger?
Oncological Disease, Fertility Preservation
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna2002025-04-072026-04-22
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
Elonva®, Puregon®, Orgalutran® - Ovarian Stimulation, Quality of Life
Phase 4RecruitingUniversity Hospital, Ghent602025-01-272025-12-26
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
Endometrial Cytology Testing, Cervical Methylation Testing - Endometrial Cancer, Methylation
Not yet recruitingYulan Ren2002024-11-042024-11-05
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Treatment Option 1 is a single-drug regimen, with oral medroxyprogesterone acetate (MPA) 500mg/d or MA 320mg/d. - Carcinoma, Endometrioid, Fertility Preservation
Not applicableRecruitingPeking University People's Hospital162024-06-212026-08-21
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Camrelizumab, Cisplatin, Nab paclitaxel - Cervical Cancer, Neoadjuvant Chemoimmunotherapy
Phase 2RecruitingTongji Hospital402024-05-082024-11-05
FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients
Luveris - Fertility Preservation
Phase 3Not yet recruitingEllen Greenblatt1402024-02-012024-01-29
Impact of Gonadotoxic Therapies on Fertility
Blood samples for analysis, Sperm samples for analysis, Satisfaction evaluation - Cancer, Fertility Issues
RecruitingMichael von Wolff70002023-12-012026-07-30
Vitrification of Oocytes Matured by CAPA-IVM
Oocyte Vitrification /Warming - Fertility Preservation
UnknownCentro de Fertilidad y Reproducción Asistida, Peru202023-12-012023-12-06
The Determinants of Fertility Preservation in TRANSgender Patients.
No intervention. - Fertility Preservation, Transgender
UnknownCentral Hospital, Nancy, France2302023-09-252024-03-26
Correlation of Oxidative Stress and Oocyte Quality in Fertility Preservation
Oxidative stress, cf-DNA, MAGENTA AI - Fertility Preservation
Not applicableCompletedClinique Ovo1792022-06-012025-03-20
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
Multi-component oncofertility care intervention - Cancer, Fertility Preservation
Phase 3RecruitingUniversity of California, San Diego28002022-01-012025-12-03

Showing 20 of 41. Sign in to see all of them.

Narrower conditions

Neoplasms (6)  ·  Breast Neoplasms (4)  ·  Endometrial Neoplasms (4)  ·  Infertility (3)  ·  Carcinoma, Endometrioid (2)  ·  Lymphoma (2)  ·  Neoplasm, Residual (2)  ·  Azoospermia (1)  ·  Behavior (1)  ·  Disease (1)  ·  Endometrial Hyperplasia (1)  ·  Gender Dysphoria (1)  ·  Lymphoma, Follicular (1)  ·  Primary Ovarian Insufficiency (1)  ·  Transsexualism (1)

Broader conditions

Neoplasms (13)  ·  Genital Diseases (10)  ·  Urogenital Diseases (10)  ·  Neoplasms by Site (9)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Genital Diseases, Female (6)  ·  Genital Neoplasms, Female (5)  ·  Urogenital Neoplasms (5)  ·  Uterine Diseases (5)  ·  Uterine Neoplasms (5)  ·  Breast Diseases (4)  ·  Neoplasms by Histologic Type (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)

Interventions

ganirelix (2)  ·  Biopsy (1)  ·  Blood Specimen Collection (1)  ·  Cisplatin (1)  ·  Desogestrel (1)  ·  Drug Therapy (1)  ·  Fertility Preservation (1)  ·  Gonadotropins (1)  ·  Leuprolide (1)  ·  Luteinizing Hormone, beta Subunit (1)  ·  Norethindrone Acetate (1)  ·  Ovariectomy (1)  ·  Ovulation Induction (1)  ·  Oxidative Stress (1)  ·  Taxes (1)

Sponsors

Central Hospital, Nancy, France (2)  ·  Erasme University Hospital (2)  ·  Fundacion Dexeus (2)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (2)  ·  Peking University People's Hospital (2)  ·  University Hospital, Clermont-Ferrand (2)  ·  Weill Medical College of Cornell University (2)  ·  Baylor College of Medicine (1)  ·  Benha University (1)  ·  Biruni University (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Centro de Fertilidad y Reproducción Asistida, Peru (1)  ·  Centrum Clinic IVF Center (1)  ·  Clinique Ovo (1)  ·  Ellen Greenblatt (1)

Countries

France (8)  ·  United States (6)  ·  Italy (5)  ·  Belgium (4)  ·  China (3)  ·  Turkey (Türkiye) (3)  ·  Canada (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Egypt (1)  ·  Netherlands (1)  ·  Peru (1)  ·  Switzerland (1)

Top investigators

Alina Ferster (1)  ·  Christine Decanter (1)  ·  Ding Ma (1)  ·  Ellen Greenblatt, MD FRCSC (1)  ·  Frederic Amant, MD,PhD (1)  ·  Glenn Schattman, MD (1)  ·  H. Irene Su, MD, MSCE (1)  ·  Isabelle Demeestere, PhD (1)  ·  Jianliu Wang, Professor (1)  ·  Kathrin Fleischer, MD, PhD (1)  ·  Michael von Wolff, Prof. Dr. (1)

Results publications

PMID 23129737, PMID 25154677, PMID 28526012, PMID 31398245, PMID 31398258, PMID 31744224, PMID 31831533, PMID 32617881, PMID 33342535, PMID 35438338, PMID 35486413, PMID 37549836, PMID 38614445, PMID 39433199, PMID 42172490, PMID 7898294

NIH funding

2023 (1)